Task Force II: Indirect and Secondary Cardiovascular Effects of Biological Terrorism Agents and Diseases

Q-fever endocarditis: microbiological, molecular, and histologic studies. J Infect Dis 2003;187:1097–106. 41. Fournier PE, Etienne J, Harle JR, et al. Myocarditis, a rare but severe manifestation of Q fever: report of 8 cases and review of the literature. Clin Infect Dis 2001;32:1440–7. 42. Pebody RG, Wall PG, Ryan MJ, et al. Epidemiological features of Coxiella burnetii infection in England and Wales: 1984 to 1994. Commun Dis Rep CDR Rev 1996;6:R128–32. 43. Tissot-Dupont H, Raoult D, Brouqui P, et al. Epidemiological features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med 1992;93:427–34. 44. Bautista-Hernandez V, Gutierrez F, Ray VG, et al. Contrictive pericarditis due to Coxiella burnetii. Ann Thorac Surg 2004;78: 326–8. 45. Lovey PY, Morabia A, Bleed D, et al. Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study. Br Med J 1999;319:284–6. 46. Ayres JG, Wildman M, Groves J, et al. Long-term follow-up of patients from the 1989 Q fever outbreak: no evidence of excess cardiac disease in those with fatigue. Q J Med 2002;95:539–46. 47. Centers for Disease Control and Prevention. Increasing rate of Salmonella enteritidis infections in the northeastern United States. MMWR 1987;36;10–1. 48. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5:607–25. 49. Swartz M. Human disease caused by foodborne pathogens of animal origin. Clin Infect Dis 2002;34 Suppl 3:S111–22. 50. Holmann EL. Nontyphiodal salmonellosis. Clin Infect Dis 2001;32: 263–9. 51. Hsu RB, Tsay YG, Chen RJ, et al. Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis 2003;36:829–34. 52. Chiu CH, Ou JT. Risk factors for endovascular infection due to nontyphoid salmonellae. Clin Infect Dis 2003;36:835–6. 53. Benenson S, Raveh D, Schlesinger Y, et al. The risk of vascular infection in adult patients with nontyphid salmonella bacteremia. Am J Med 2001;110:60–3. 54. Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of samonella infection. Medicine 1987;66:349–88. 55. Fernandez Guerrero ML, Aguado JM, Arribas A, et al. The spectrum of cardiovascular infections due to Salmonella enterica: a review of clinical features and factors determining outcome. Medicine (Baltimore) 2004;83:123–38. 56. Baysal K, Sancak R, Ozturk F, et al. Cardiac involvement due to Salmonella typhid infections in children. Ann Trop Paediatr 1998;18: 23–5. 57. Wanby P, Olsen B. Myocarditis in a patient with salmonella and campylobacter enteritis. Scan J Infect Dis 2001;33:860–2. 58. Ruff MJ, Lamkin H, Jr., Braun J, et al. Melioidosis complicated by pericarditis. Chest 1976;69:227–9. 59. Majid AA. Successful surgical management of a case of pulmonary and pericardial melioidosis. Aust N Z J Surg 1990;60:139–41. 60. Tanyaowalak W, Sunthornyothin S, Luengtaviboon K, et al. Mycotic aneurysm caused by Burkholderia pseudomallei with negative blood cultures. Scand J Infect Dis 2004;36:68–70. 61. Choonhakarn C, Jirarattanapochai K. Cutaneous polyarteritis nodosa: a report of a case associated with melioidosis (Burkholderia pseudomallei). Intern J Dermatol 1998;37:433. 62. Centers for Disease Control and Prevention. Recognitions of illness associated with the intentional release of a biologic agent. MMWR Morb Mortal Wkly Rep 2001;50:893–7. 63. Centers for Disease Control and Prevention. Recognition of illness associated with exposure to chemical agents—United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:938–40.